Marine Shale Pro. v. State, D. of Health

572 So. 2d 280, 1990 WL 180110
CourtLouisiana Court of Appeal
DecidedNovember 14, 1990
Docket90 CA 0575
StatusPublished
Cited by10 cases

This text of 572 So. 2d 280 (Marine Shale Pro. v. State, D. of Health) is published on Counsel Stack Legal Research, covering Louisiana Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Marine Shale Pro. v. State, D. of Health, 572 So. 2d 280, 1990 WL 180110 (La. Ct. App. 1990).

Opinion

572 So.2d 280 (1990)

MARINE SHALE PROCESSORS, INC.
v.
STATE of Louisiana, Through the DEPARTMENT OF HEALTH AND HOSPITALS, et al.

No. 90 CA 0575.

Court of Appeal of Louisiana, First Circuit.

November 14, 1990.

*282 Nicholas F. Larocca, Jr., Lippman, Mahfouz, Martin & Larocca, Morgan City, for plaintiff/appellant.

George W. Becker, Staff Atty., New Orleans, for State of La., David Ramsey and Dr. Georgia Bryant.

Elwood C. Stevens, Jr., Kleinpeter, Schwartzberg & Stevens, Morgan City, Daniel E. Becnel, Reserve, for intervenors Glynn Patrick Price, et al.

Lloyd J. Lunceford, Baton Rouge, for Bd. of Sup'rs of LSU & AG & Mechanical College thru LSU Medical Center.

Before LOTTINGER, SHORTESS and CARTER, JJ.

SHORTESS, Judge.

Marine Shale Processors, Inc. (MSP) commenced these proceedings with a show cause pleading styled "Motion to Perpetuate Evidence and For a Protective Order," alleging that the Louisiana Department of Health and Hospitals (DHH) conducted a study[1] involving five cases of an unusually high incidence of neuroblastoma (a rare form of childhood cancer) found in St. Mary Parish, and that the data, documents, preliminary drafts, and final report generated from the study were essential to both pending and anticipated tort litigation alleging some connection between the activities at a nearby MSP plant and the cases of neuroblastoma. MSP alleges that the data could be discarded upon dissemination of the final report and prays for a protective order to preserve the evidence, and that it be allowed to depose the custodian.[2]

DHH opposed the motion, stating that none of the items would be discarded and that the privilege found at LSA-R.S. 44:3 A(7) excludes them from discovery.[3] DHH also asserted that it was not in actual possession of the materials, and that Louisiana State University Medical Center (LSU-MC), by virtue of a contractual arrangement, had conducted the study and was in actual possession of the items sought.

The plaintiffs in one of the pending tort suits (tort plaintiffs) intervened and moved to consolidate this matter with their suit. A show cause hearing was conducted, the motion to consolidate was denied, and the trial court ruled that the inquiry would follow the procedural constraints articulated by us in Freeman v. Guaranty Broadcasting Corporation, 498 So.2d 218 (La.App. 1st Cir.1986). In Freeman we held that LSA-R.S. 44:3 requires a contradictory hearing and a "meaningful opportunity... for cross-examination and other evidentiary processes to contradict the claim of privilege." Id. at 225. We detailed a procedure for in camera inspection of the documents, for the testimony of a representative of the custodian of the documents setting forth "with specificity" the privilege asserted, and then examination by *283 the trial court to result in deletion "or withholding in toto" of any matters that come within the scope of the privilege. Id. at 226.[4]

MSP brought these proceedings pursuant to LSA-C.C.P. art. 1429, which provides the method for the perpetuation of testimony, including, most notably, that litigation be anticipated and a listing of the names of the expected adverse parties; LSA-C.C.P. art. 1430 requires that these parties be served. LSA-C.C.P. art. 1431 requires a finding by the trial court that perpetuation "may prevent a failure or delay of justice." The scheme clearly envisions use of an extraordinary discovery method where resort to normal discovery is made impossible by the absence of pending litigation. The federal courts interpreting the federal model for our article 1429, Rule 27, of the Federal Rules of Civil Procedure, have recognized that perpetuation of testimony is not a substitute for discovery, but rather is available in "special circumstances to preserve testimony which could otherwise be lost." Ash v. Cort, 512 F.2d 909, 912 (3d Cir.1975), rev'd on other grounds sub nom., Cort v. Ash, 422 U.S. 66, 95 S.Ct. 2080, 45 L.Ed.2d 26 (1975). See also In re: Eisenberg, 654 F.2d 1107 (5th Cir.1981); Lombard's, Inc. v. Prince Manufacturing, 753 F.2d 974 (11th Cir.1985), cert. denied, 474 U.S. 1082, 106 S.Ct. 851, 88 L.Ed.2d 892 (1986).

Conscientiously adhering to Freeman, the trial court conducted three separate hearings, allowing LSU-MC to intervene after the second hearing. The materials were inspected in camera following the second hearing, and some information was excised. A third hearing, with LSU-MC conducting the defense, produced the testimony of the LSU-MC faculty members involved in the study and resulted in additional deletions by the trial court. MSP, LSU-MC and the tort plaintiffs all appeal the final judgment, which orders production of all documents to which no privilege has been asserted by LSU-MC and of the remaining documents as censored by the court.

We find it unnecessary to dwell upon the articles on perpetuation, i.e., LSA-C.C.P. arts. 1429-1431, and we pretermit procedural issues because our review of the record convinces us that the trial court erred in construing the privilege created by LSA-R.S. 44:3 A(7).[5]

We begin by dismissing as specious the contention that the study was not a "public health disease investigation" because neuroblastoma is not infectious and the numbers of cases and geographical area are limited. The investigation was clearly to determine whether there existed a connection between environmental conditions and a disease. The federal government specifically recognizes, in its creation of the Public Health Service and the office of the Surgeon General, that environmental impact upon human health is a matter of public concern. See 42 U.S.C. § 242b(d).[6]*284 We believe it in the public interest to construe the language in our statute sufficiently broad to embrace this form of cancer.

The language of LSA-R.S. 44:3 A(7) exempts disclosure under the Public Records Act of "[r]ecords containing the identity of a subject of a public health disease investigation ... or ... which would tend to reveal the identity of such a subject" (emphasis ours). This privilege creates a reasonable expectation of privacy on the part of participants in such a study that their identities will in no manner be disclosed to the public. In Trahan v. Larivee, 365 So.2d 294 (La.App. 3d Cir.1978), writ denied, 366 So.2d 564 (La.1979), the Third Circuit recognized that the right of privacy guaranteed by Article I, § 5, of the Louisiana Constitution (1974) prohibited disclosure of performance evaluations of public employees. The reasoning would apply a fortiori to the instance of private citizens who willingly participate in a public health study. See Plaquemines Parish Commission Council v. Delta Development Co.,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Williams v. Dauthier
M.D. Louisiana, 2024
Kaptein v. Kaptein
221 So. 3d 231 (Louisiana Court of Appeal, 2017)
Haybeych v. JPMorgan Chase Bank, National Ass'n
180 So. 3d 491 (Louisiana Court of Appeal, 2015)
Alfonso Haybeych v. Jpmorgan Chase Bank Na
Louisiana Court of Appeal, 2015
Williams Law Firm v. BD. OF SUP. OF LA. STATE UNIV.
878 So. 2d 557 (Louisiana Court of Appeal, 2004)
Skamangas v. Stockton
867 So. 2d 1009 (Louisiana Court of Appeal, 2004)
Gaines v. Bruscato
712 So. 2d 552 (Louisiana Court of Appeal, 1998)
Opinion Number
Louisiana Attorney General Reports, 1993

Cite This Page — Counsel Stack

Bluebook (online)
572 So. 2d 280, 1990 WL 180110, Counsel Stack Legal Research, https://law.counselstack.com/opinion/marine-shale-pro-v-state-d-of-health-lactapp-1990.